Professional Documents
Culture Documents
Formulation and Development
Formulation and Development
AND
DEVELOPMENT
DOSAGE FORM CONSIDERATIONS
SCHEDULE Y
APPENDIX-I
ACID RESISTANT
CONCEAL TASTE
RATE CONTROLLED
TOPICAL APPLICATIONS
INHALATIONS THERAPY
GENERAL
CONSIDERATIONS
DRUG RELEASE PROFILE
BIOAVAILABILITY
CLINICAL EFFECTIVENESS
THERAPEUTIC CONSIDERATIONS
NATURE OF ILLNESS
MANNER IN WHICH IT IS TREATED
AGE
ANTICIPATED CONDITION OF THE
PATIENT
DIFFERENT TYPES
LIQUID DOSAGE FORMS
SOLUTIONS
ORAL SOLUTIONS
SYRUPS
ELIXIRS
PARENTERALS
SUSPENSIONS
EMULSIONS
POWDERS
TABLETS
SUSTAINED RELEASE
ENTERIC COATED
CAPSULES
HARD GELATIN
SOFT GELATIN
SEMISOLID DOSAGE
FORMS
OINTMENTS
SUPPOSITORIES
PESSARIES
CREAMS
INHALATIONS
AEROSOLS
CONSTITUENTS OF A
DOSAGE FORM
DRUG
VEHICLE
PHARMACEUTICAL
INGREDIENTS AND EXCIPIENTS
DRUG
DATA FROM PREFORMULATION
STUDIES
eg:solubility data
stability data etc.
PHARMACEUTICAL
INGREDIENTS
ANDEXCIPIENTS
Pharmaceutical bases
pharmaceutical
excipients
Non
propreitary,chemical,commercial
names
Empirical and chemical formulae
Pharmaceutical specifications
Chemical and physical properties
Incompatibilities
Interactions with other excipients
and drug substances
Regulatory status
Application in pharmaceutical
HARMONIZATION OF
STANDARDS
TYPES
INHERENT
eg:
Sulfur(yellow),riboflavin(yellow),cupric
sulfate(blue),ferrous sulfate(red).